NCT07438626
- Conditions
- Phase II, SMARCB1-deficient Renal Medullary Carcinoma, Sacituzumab, +1 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Phase II
Explore clinical trials studying Phase II. Study availability and eligibility vary by location and protocol.
4 public trials
1 recruiting study
Phase II trial results
Not yet recruiting
A Phase II Study of Ivonescimab Combined With Intraperitoneal Paclitaxel in Patients With High-Grade Metastatic Appendiceal Adenocarcinoma (AA)
NCT07753824
- Conditions
- Adenocarcinoma, Adenocarcinoma, Mucinous, Appendiceal Adenocarcinoma, +10 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
Not yet recruiting
Phase 2 Study Of Imetelstat for Patient With Myelodysplastic/Myeloproliferative Neoplasms
NCT07549451
- Conditions
- Disease, Imetelstat, Myelodysplastic (MDS) / Myeloproliferative (MPN) Diseases, +3 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Withdrawn
Phase 2 Trial Of S-531011 With RadScopal In Previously Treated Metastatic Colorectal Cancer
NCT07720115
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +12 more
- Locations
-
Not specified